Background
==========

*Acinetobacter baumanni* is a non-fermentative, aerobic, gram-negative bacillus, and is an opportunistic pathogen with global distribution. It is frequently found in elderly patients and cancer patients with compromised immune function, especially in intensive care units. With the use of broad-spectrum antibiotics, immunosuppressive drugs, and glucocorticoids, *A. baumannii* (AB) has become a major nosocomial pathogen species \[[@B1]\]. Multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan drug-resistant (PDR) *A. baumannii* strains are increasingly prevalent \[[@B2]\]. MDR-AB refers to *A. baumannii* strains that are resistant to at least three of the following five types of antimicrobial agents: cephalosporins, carbapenems, β-lactamase inhibitors (including piperacillin/tazobactam, cefoperazone/sulbactam, ampicillin/sulbactam), fluoroquinolones, and aminoglycosides \[[@B2]-[@B4]\].

Bacteriophage therapy is a potential alternative treatment for multidrug-resistant bacterial infections \[[@B5]\]. A bacteriophage is a bacterial virus that can lyse and kill the host cell. Phage-related studies have gone through three stages. Félix d'Herelle discovered bacteriophage for the treatment of bacterial infections in 1917 \[[@B6]\]. After the emergence of antibiotics in the 1940s, phages were seldom used for therapeutic purposes, and mainly functioned as molecular and genetic research tools. With the recent emergence of multidrug-resistant bacteria, however, there has been renewed interest in methods of phage therapy \[[@B7]\]. In this study we isolated a lytic bacteriophage IME-AB2, and compared biological characteristics and genomic sequence with other *Acinetobacter baumannii* phages. The genomes of *A. baumannii* phages IME-AB2, *A. baumannii* AB1, *A. baumannii* AP22, and A. *baumannii* phiAC-1 were compared thoroughly in this study. To our knowledge this is the first report of comparison of the characteristics and complete genome sequence of *Acinetobacter baumannii* bacteriophages. A clear understanding of its genes is conducive to the treatment of multidrug-resistant *A. baumannii* in the future.

Results
=======

Isolation of a lytic bacteriophage against multidrug-resistant *A. baumannii*
-----------------------------------------------------------------------------

*A. baumannii* strain MDR-AB2, isolated from a sputum sample of a patient with pneumonia at PLA Hospital 307, was resistant to multiple antibiotics (Table  [1](#T1){ref-type="table"}). The bacteria was used to screen bacteriophages in sewage samples from PLA Hospital 307. The isolated phage was designated as vB_AbaM-IME-AB2 following the recommendation by International Committee on Taxonomy of Viruses in phage nomenclature \[[@B8]\]. The pahge IME-AB2 could form clear plaques in the double-layer assay and clear its host's suspension in just 4 hours (Figure  [1](#F1){ref-type="fig"}), indicating that it is a lytic phage. In order to check the development of resistance, we had extended the period of the experiment to 24 h. The result indicated that the bacterial suspension became turbid finally. The final suspension was plated on solid LB culture and then some single bacterial clones were picked to be used for 16 s rDNA sequencing. The sequences of 16 s rDNA proved that the final suspension was *A. baumannii* that developed resistance to IME-AB2. The phage particles were concentrated with PEG6000 and then purified with a cesium chloride gradients density to a titer of 1 × 10^11^ pfu/ml. Observation under an electron microscope showed that the phage IME-AB2 consisted of an icosahedral head and a contractile tail. The total length of the phage from the top of the head to the bottom of the tail was about 160 nm, with the head measuring approximately 61.2 nm, and the tail about 90 nm. This morphology suggested that phage IME-AB2 should be classified as a member of the *Myoviridae* family (Figure.  [2](#F2){ref-type="fig"}). Among the 22 clinical strains of *A. baumannii*, only three strains of *A. baumannii* (MDR-AB1139, MDR-AB2 and MDR-AB11) could be lysed by the phage IME-AB2.

###### 

**Antibiotic resistance profile of*A. baumannii*strain MDR-AB2**

       **Antibiotics**       **MIC (μg/ml)**   **Sensitivity**      **Antibiotics**       **MIC (μg/ml)**   **Sensitivity**
  ------------------------- ----------------- ----------------- ------------------------ ----------------- -----------------
         Ampicillin               ≥ 32            Resistant          nitrofurantoin            ≥ 512           Resistant
        Ciprofloxacin              ≥ 4            Resistant       ampicillin/sulbactam         ≥ 32            Resistant
         Gentamicin               ≥ 16            Resistant            aztreonam               ≥ 64            Resistant
          Imipenem                ≥ 16            Resistant             cefepime               ≥ 64            Resistant
          Meropenem               ≥ 16            Resistant            cefotetan               ≥ 64            Resistant
        Piperacillin              ≥ 128           Resistant           ceftazidime              ≥ 64            Resistant
   Piperacillin/tazobactam        ≥ 128           Resistant           ceftriaxone              ≥ 64            Resistant
         Tobramycin               ≥ 16            Resistant        cefuroxime axetil           ≥ 64            Resistant
        Cotrimoxazole             ≥ 320           Resistant        cefuroxime sodium           ≥ 64            Resistant
        Levofloxacin               ≥ 8            Resistant      cefoperazone/sulbactam        ≥ 64            Resistant

![**The MDR-AB2 suspension at the different optical density (OD600nm) reached to 0.4 from 1.6 and reached to 0.08 from 0.6 respectively after added 200ul IME-AB2 (1 × 10**^**11**^**pfu/ml) to the 10 ml MDR-AB2 suspension.** It clear its host's suspension in just 4 hours. The control shows increasing OD600nm. The MDR-AB2 suspension added with IME-AB2 finally became turbid in 24 hours.](1471-2180-14-181-1){#F1}

![**Transmission electron microscopy of phage IME-AB2.** The bidirectional arrows indicated the length of intact phage, phage tail and head. The bar represents a length of 200 nm.](1471-2180-14-181-2){#F2}

Growth and lytic characteristics of IME-AB2
-------------------------------------------

To determine the optimal multiplicity of infection (MOI) of IME-AB2, the phage and its host cells were mixed at various ratios, and incubated for 3.5 h at 37°C. The results indicated that a MOI of 20 gave the highest production of phage progeny (3.5 × 10^11^ pfu/ml). To examine the host adsorption ability of phage IME-AB2, host bacteria were infected with IME-AB2 at a MOI of 0.1 and incubated at 37°C. Aliquots were taken at 0, 3, 6, 9, 12, 15, and 18 min post-infection and assayed for the absorbed phage by titration using the double-layer method. The percentages of phage absorption at different time points were plotted (Figure  [3](#F3){ref-type="fig"}a). The results showed that phage IME-AB2 had an adsorption rate of 50% within 3 min, 80% within 6 min and 99% within 9 min.

![**Biological characteristics of phage IME-AB2. a**. Host adsorption ability of phage IME-AB2. **b**. One-step growth curve of phage IME-AB2.](1471-2180-14-181-3){#F3}

For one-step growth curve analysis, MDR-AB2 cells (OD600 = 0.3) were infected with phage IME-AB2 at a MOI of 0.1. The bacteriophage was allowed to adsorb for 15 min at 37°C \[[@B9]\]. The mixture was then centrifuged at 12,000 × g for 30 s to remove unadsorbed phage particles, and the resultant pellet was re-suspended in 5 ml of LB medium. Samples were incubated at 37°C and collected every 10 min during 0--60 min, as well as at 90 and 120 min \[[@B10]\]. As shown in Figure  [3](#F3){ref-type="fig"}b, the latent period of phage IME-AB2 lasted for 20 min, the burst period reached a peak at 30 min, and the phage multiplication reached the final plateau phase at 50 min. The burst size of phage IME-AB2 was determined to be 62 pfu/cell (burst size = the total number of phages liberated at the end of one cycle of growth /the number of infected bacteria) \[[@B11]\].

Analysis of the phage proteins and genome
-----------------------------------------

Purified phage particles were denatured in loading buffer (50 mM Tris--HCl, 2% Sodium Dodecyl Sulfate-polyacrylamide, 0.1%Bromophenol blue, 10% Glycerol and 1% β-Mercaptoethanol) and heated in a boiling water bath for 5 min, followed by separation of the proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The results indicated that the structural proteins of phage IME-AB2 showed a pattern of nine protein bands in 10% SDS-PAGE gel, with molecular masses ranging from 15--100 kDa (Figure  [4](#F4){ref-type="fig"}a). The most abundant protein band in the gel above 35 kDa was analyzed with liquid sampling Mass Spectrometry (LS-MS) and proved to be the phage putative capsid protein.

![**Protein and genomic DNA analysis of phage IME-AB2. a**. SDS-PAGE gel (10%) of whole protein from phage IME-AB2. Molecular weights of protein marker was indicated by lines. **b**. Endonuclease digestion analysis of phage IME-AB2 genomic DNA. Phage IME-AB2 genomic DNA was digested with the restriction enzyme *Nde*I, *HincII* and *HindIII*. The digested DNA fragments were separated by 1% agarose gel electrophoresis. M, DNA molecular weight marker; Lanes 1, undigested phage IME-AB2 genomic DNA; lane 2, 3, 4, genomic DNA digested with *NdeI* , *HincII* and *HindIII*, respectively.](1471-2180-14-181-4){#F4}

The genome analysis indicated that phage IME-AB2 has a double-stranded DNA genome, approximately 40 kb in size. The genome of phage IME-AB2 could be digested with endonuclease *Nde*I, *HincII* and *HindIII* (Figure  [4](#F4){ref-type="fig"}b). It was found that endonuclease enzymes, *HindIII* and *HincII*, have the 35 and 16 cutting sites on the genome of phage IME-AB2 respectively by Vector NTI \[[@B12]\]. Compared to other *A. baumannii* complete genome , the two endonucleases also have most restriction enzyme cutting sites on them.

High-throughput sequencing of the phage genomic DNA generated 311,503 valid reads with which the complete sequence of the genome was assembled using both Velvet and CLC Genomic Workbench, with an average coverage of 785 ×  \[[@B13]\]. The complete genome of phage IME-AB2 consists of 43,665 bp, with an average GC content of 37.5% (Figure  [5](#F5){ref-type="fig"}). Annotation results showed that the genome encodes 82 coding sequences (CDSs) (GenBank Assession number: JX976549). The classification of the 82 CDSs is shown in Table  [2](#T2){ref-type="table"} and Figure  [6](#F6){ref-type="fig"}. The complete genome of IME-AB2 is organized into three functional units which encoding structural proteins, metabolic proteins and packaging-associated proteins respectively. No tRNA was found in the genome of IME-AB2, and no significant proteins considered to be markers of temperate bacteriophages were identified. Running blastn showed that the isolated IME-AB2 has a high similarity to *Acinetobacter* phage AB1 (Genbank Accession Number: HM368260.1), *Acinetobacter* phage AP22 (Genbank Accession Number: HE806280.1) and *Acinetobacter* phage phiAC-1 (GenBank accession number: JX560521), which were isolated in China, Russia and Korea respectively. The phage AB1, AP22 or phiAC-1 has a genome of about 45 kb and owns a coverage of 65%, 50%, 8% respectively when compared with the isolated phage IME-AB2. Genomic annotation found that IME-AB2 encodes 82 CDSs, AB1 85 CDSs, AP22 89 CDSs, phiAC-1 82 CDSs. The 82 CDSs from IME-AB2 shared 63 homologues with AB1, 60 homologues with AP22 and 36 homologues with phiAC-1 respectively (Table  [3](#T3){ref-type="table"}). Totally, 22 of the 82 CDSs encoded by IME-AB2 were identified to be putatively functional. Genomic analysis revealed that the bacteriophage IME-AB2 was most closely related to AB1. A nucleotide alignment of the four *Acinetobacte*r *baumannii* phages showed that some functional regions are highly homologous, with no significant rearrangements observed (Table  [3](#T3){ref-type="table"} and Figure  [7](#F7){ref-type="fig"}). It revealed a stable area. Stability is suggested from the high level of nucleotide identity, lack of inversions and other major rearrangements, and the stabilizing selection inferred for virtually all genes harboring synonymous and non-synonymous mutations \[[@B14]\]. Functional related genes are sequential, yet there are a lot of breakpoint modules obviously and some sections of these strains of phages are nonhomologous (Table  [3](#T3){ref-type="table"} and Figure  [7](#F7){ref-type="fig"}). It illustrated that these structural genes had occurred in the extensive structural rearrangements during evolution. Bacteriophages are the most diverse and abundant biological entities in nature environment. Most of them can hardly to be found homologous to another bacteriophage, which means evolutionary success obtained by bacteriophages. Furthermore, the diversity is such that even genes with required functions cannot always be recognized. During bacteriophage evolution,the elimination or recombination of genes result in the diversity and meanwhile confer a selective advantage to survive and infect so that phages can better adapt to host bacteria.

![**Circular map of the IME-AB2 genome prepared using CGView.** The outer ring denotes the IME-AB2 genome and CDSs. The inner rings show G + C content and G + C skew, where peaks represent the positive (outward) and negative (inward) deviation from the mean G + C content and G + C skew, respectively.](1471-2180-14-181-5){#F5}

###### 

Functional classification of the 82 CDSs in the IME-AB2 genome

  **Category**                                                                  **CDSs and putative functions**
  ----------------------------------------------------------------------------- -------------------------------------------------------------------------------
  Structural proteins                                                           CDS.12 putative capsid protein.
  CDS.13 putative structural protein.                                           
  CDS.24 putative phage head protein.                                           
  CDS.71 putative tail fiber.                                                   
  CDS.72 similar to the N-terminal region of tail fiber protein.                
  CDS.74 putative baseplate J-like protein.                                     
  CDS.77 putative phage baseplate assembly protein.                             
  Metabolic proteins                                                            CDS.06 putative cobalt transport protein.
  CDS.08 putative RNA polymerase.                                               
  CDS.33 putative binding HTH domain or homeodomain-like.                       
  CDS.47 putative bacteriophage-associated immunity protein.                    
  CDS.52 putative HNH endonuclease domain protein.                              
  CDS.66 putative nucleoside triphosphate pyrophosphohydrolase.                 
  CDS.68 putative lysozyme family protein.                                      
  CDS.81 putative lysozyme protein.                                             
  Replication/packaging-associated proteins                                     CDS.26 putative phage head portal protein.
  CDS.27 putative phage terminase, large subunit.                               
  CDS.28 putative phage terminase,small subunit.                                
  CDS.50 putative replicative DNA helicase.                                     
  CDS.51 putative primosomal protein.                                           
  CDS.58 putative transcriptional regulator.                                    
  CDS.62 putative recombinational DNA repair protein.                           
  Other hypothetical proteins                                                   CDS.1,2,3,4,5,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,29,30,31,
  32,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,51,53,54,55,56,57,59,60,   
                                                                                61,63,64,65,67,69,70,73,75,76,78,79,80,82.

![**Genome map of phage IME-AB2.** Arrows indicate putative CDSs, along with their orientations. Functionally assigned genes are differently colored (purple, structural gene; green, metabolic gene; orange, replication/packaging-associated gene; blue, other gene). Promoters are illustrated as green arrowheads, while terminators are displayed as red arrowheads.](1471-2180-14-181-6){#F6}

###### 

**Comparative genomic analysis of*A. baumannii*phage IME-AB2,*A. baumannii*phage AB1,*A. baumanni i*phage AP22, and*A3 baumannii*phage phiAC-1**

  **IME-AB2 (82CDSs)**   **AB1 (85CDSs)**   **Score (bits)**   **E-value**   **phiAC-1 (82CDSs)**   **Score (bits)**   **E-value**   **AP22 (89CDSs)**   **Score (bits)**   **E-value**
  ---------------------- ------------------ ------------------ ------------- ---------------------- ------------------ ------------- ------------------- ------------------ -------------
  **CDS.01**             gp01               134                9e-35         0055                   190                1e-51         gp42                290                1e-81
  **CDS.02**             gp02               192                4e-52         0054                   205                3e-56         gp41                130                9e-34
  **CDS.03**             gp03               895                0.0           0053                   645                0.0           gp40                813                0.0
  **CDS.04**             gp04               334                5e-95         0052                   207                1e-56         gp39                325                4e-92
  **CDS.05**             gp06               345                2e-98         0051                   220                1e-60         gp38                329                2e-93
  **CDS.06**                                                                                                                                                                 
  **CDS.07**             gp08               57                 8e-12         0050                   45                 3e-08         gp36                52                 3e-10
  **CDS.08**             gp09               270                7e-76         0049                   99                 3e-24         gp35                262                3e-73
  **CDS.09**             gp10               150                4e-40         0048                   128                2e-33         gp34                150                4e-40
  **CDS.10**             gp12               298                3e-84         0047                   221                5e-61         gp32                299                2e-84
  **CDS.11**             gp13               74                 1e-16         0046                   75                 6e-17         gp31                65                 4e-14
  **CDS.12**             gp15               207                2e-56         0043                   208                1e-56         gp30                250                2e-69
  **CDS.13**             gp16               120                2e-30         0042                   124                1e-31         gp29                99                 6e-24
  **CDS.14**             gp17               523                e-151         0041                   402                e-115         gp28                546                e-158
  **CDS.15**                                                                                                                                                                 
  **CDS.16**             gp19               144                4e-38         0038                   31                 5e-04         gp27                36                 1e-05
  **CDS.17**                                                                                                                                                                 
  **CDS.18**                                                                                                                                                                 
  **CDS.19**                                                                                                                                                                 
  **CDS.20**                                                                                                                                                                 
  **CDS.21**             gp23               55                 4e-11                                                                 gp22                71                 9e-16
  **CDS.22**                                                                                                                                                                 
  **CDS.23**                                                                 0022                   40                 1e-06         gp21                39                 2e-06
  **CDS.24**             gp27               414                e-119         0031                   325                6e-92         gp18                404                e-116
  **CDS.25**             gp28               204                4e-56                                                                                                         
  **CDS.26**             gp30               831                0.0           0029                   658                0.0           gp17                804                0.0
  **CDS.27**             gp31               627                0.0           0028                   64                 7e-13         gp16                60                 8e-12
  **CDS.28**             gp33               305                2e-86         0027                   22                 0.82          gp15                20                 2.7
  **CDS.29**             gp34               31                 6e-04         0038                   35                 3e-05         gp27                32                 3e-04
  **CDS.30**             gp34               35                 2e-05                                                                 gp14                30                 6e-04
  **CDS.31**             gp34               31                 6e-04                                                                                                         
  **CDS.32**             gp35               149                1e-39                                                                 gp12                83                 1e-19
  **CDS.33**             gp36               112                1e-28                                                                 gp10                114                4e-29
  **CDS.34**                                                                                                                                                                 
  **CDS.35**             gp39               133                6e-35                                                                 gp05                137                4e-36
  **CDS.36**                                                                                                                                                                 
  **CDS.37**                                                                                                                                                                 
  **CDS.38**             gp40               147                3e-39         0010                   50                 1e-09         gp02                124                3e-32
  **CDS.39**             gp42               186                1e-50         0021                   152                1e-40                                                 
  **CDS.40**                                                                                                                         gp88                139                8e-37
  **CDS.41**             gp43               92                 3e-22                                                                                                         
  **CDS.42**             gp44               152                5e-40                                                                 gp87                71                 1e-15
  **CDS.43**             gp45               97                 7e-24                                                                 gp86                95                 2e-23
  **CDS.44**             gp46               379                e-108                                                                 gp85                390                e-112
  **CDS.45**             gp47               388                e-111                                                                 gp84                186                6e-50
  **CDS.46**             gp48               68                 5e-15                                                                 gp83                70                 9e-16
  **CDS.47**             gp49               72                 2e-16         0019                   42                 2e-07         gp82                71                 4e-16
  **CDS.48**             gp50               192                1e-52                                                                                                         
  **CDS.49**             gp51               126                8e-33         0009                   42                 2e-07         gp79                159                9e-43
  **CDS.50**             gp52               863                0.0                                                                   gp77                619                e-180
  **CDS.51**             gp53               204                2e-55                                                                 gp76                157                2e-41
  **CDS.52**                                                                                                                                                                 
  **CDS.53**             gp54               130                5e-34                                                                 gp75                133                7e-35
  **CDS.54**                                                                                                                                                                 
  **CDS.55**             gp57               150                5e-40                                                                 gp72                128                3e-33
  **CDS.56**                                                                                                                                                                 
  **CDS.57**             gp60               72                 3e-16                                                                 gp69                74                 8e-17
  **CDS.58**             gp62               216                6e-59                                                                 gp68                295                4e-83
  **CDS.59**             gp63               153                6e-41                                                                                                         
  **CDS.60**             gp64               187                9e-51                                                                 gp66                192                2e-52
  **CDS.61**                                                                                                                         gp65                123                8e-32
  **CDS.62**             gp66               594                e-173                                                                                                         
  **CDS.63**             gp67               489                e-141                                                                 gp63                38                 2e-05
  **CDS.64**             gp68               189                2e-51                                                                 gp62                187                5e-51
  **CDS.65**             gp70               59                 2e-12                                                                 gp61                60                 8e-13
  **CDS.66**             gp71               125                5e-32                                                                                                         
  **CDS.67**             gp72               143                5e-38         0079                   80                 1e-18         gp59                128                2e-33
  **CDS.68**                                                                                                                                                                 
  **CDS.69**             gp74               171                3.00E-46                                                              gp56                174                4e-47
  **CDS.70**             gp75               175                2e-47                                                                 gp55                174                3e-47
  **CDS.71**             gp76               221                4e-60         0069                   189                1e-50         gp54                252                1e-69
  **CDS.72**             gp77               304                1e-85         0068                   216                3e-59         gp53                313                2e-88
  **CDS.73**             gp78               418                e-120         0067                   332                3e-94         gp52                421                e-121
  **CDS.74**             gp79               790                0.0           0066                   585                e-170         gp51                796                0.0
  **CDS.75**             gp80               213                1e-58         0065                   164                4e-44         gp50                214                6e-59
  **CDS.76**                                                                                                                         gp49                59                 2e-12
  **CDS.77**             gp81               429                e-123         0064                   200                2e-54         gp48                430                e-123
  **CDS.78**             gp82               575                e-167         0063                   437                e-125         gp47                573                e-166
  **CDS.79**                                                                 0061                   124                4e-32         gp46                170                5e-46
  **CDS.80**             gp83               352                e-100         0060                   277                1e-77         gp45                351                e-100
  **CDS.81**             gp84               710                0.0           0057                   368                e-104         gp44                715                0.0
  **CDS.82**             gp85               77                 6e-18         0056                   61                 6e-13         gp43                145                2e-38

IME-AB2 is the reference for alignments and comparisons to the three other strains (AB1,phiAC-1 and AP22).

![**Multiple genome alignment performed using Mauve software (**<http://asap.ahabs.wisc.edu/mauve/>**) and the chromosomes of*A. baumannii*IME-AB2,*A. baumannii*AB1,*A. baumannii*AP22, and A.*baumannii*phiAC-1. IME-AB2 is the reference for alignments and comparisons to the three other strains.** Boxes with identical colors represent local colinear blocks (LCB), indicating homologous DNA regions shared by two or more chromosomes without sequence rearrangements. LCBs indicated below the horizontal black line represent reverse complements of the reference LCB.](1471-2180-14-181-7){#F7}

Structural proteins
-------------------

Seven CDSs encoding structural proteins were identified in the phage IME-AB2. The putative capsid protein (CDS.12) is similar to that of phage AB1 (gp15), phage AP22 (gp30), phage phiAC-1 (0043). Phage AB1 (gp27), phage AP22 (gp18), phage phiAC-1 (0031) also share homology to the putative phage head protein encoded by IME-AB2 CDS.24. CDS.71 and CDS.72 of phage IME-AB2 are identified to be associated with tail fiber protein. CDS.74 and CDS.77 of phage IME-AB2 are predicted to encode proteins responsible for baseplate. These two related proteins can be found similar area in the other three phages. The results also demonstrate the phage tail related proteins generally cluster together (Table  [3](#T3){ref-type="table"}).

Metabolic proteins
------------------

A unique feature of the IME-AB2 genome is that it encodes cobalt transport protein (CDS.6). Notably, cobalt is a cofactor and is required by enzymes from bacteria \[[@B15]\]. It is possible that these metabolic enzymes benefit phage by enhancing the metabolism of the infected bacterial cell, which could in turn increase phage proliferation. No similar cobalt proteins were found in the other three phages sharing homology with IME-AB2. CDS.8 encodes a putative RNA polymerase protein. It is necessary for constructing RNA chains using DNA genes as templates, a process called transcription. Transcription of most double-stranded DNA bacteriophages rely on their host bacteria \[[@B16]\]. The putative CDS.33 of IME-AB2 is predicted to encode HTH domains which have been recruited to a wide range of functions beyond transcription regulation, such as DNA repairing and replication, RNA metabolism and protein-protein interactions in diverse signaling contexts. Beyond their basic role in mediating macromolecular interactions, the HTH domains have also been incorporated into the catalytic domains of diverse enzymes \[[@B17]\]. In functional terms, the HNH endonuclease domain (CDS.52) is found in CRISPR-related proteins. CRISPR functions as a prokaryotic immune system, in that it confers resistance to exogenous genetic elements \[[@B18]\]. CDS.47 is predicted to be a putative bacteriophage-associated immunity protein, which was considered to be responsible for phage superinfection immunity \[[@B19]\]. CDS.68 and CDS.81 are putative lysozyme family protein. Unlike, CDS.0057, 0058, 0059 encoded by phiAC-1, which are putative lysozyme-like domain protein and adjacent to each other, the two lysozyme-like proteins from IME-AB2 are not clustered.

Packaging-associated proteins
-----------------------------

In the four similar *Acinetobacter baumannii* phages, the genetic elements encoding the products involved in the packaging system are commonly found adjacent to one another in the phage genomes. Packaging system is generally composed of big subunit (CDS.27) and small subunit (CDS.28). Usually, the two subunits of the terminase and head portal protein (CDS.26) are closely connected in the packaging system, while the portal protein is a bacteriophage component that forms a hole, or portal, enabling DNA passage during packaging and ejection \[[@B20]\]. It also forms the junction between the phage head (capsid) and the tail proteins.

Discussion
==========

With the emergence of a growing number of drug-resistant bacterial species, and the difficulties surrounding the development of novel antibiotics \[[@B21]\], exploring novel or alternative therapeutic methods is imperative. The recent renaissance of bacteriophage therapy may provide new treatment strategies for combatting drug-resistant bacterial infections. Although a large number of work on phage therapy in human disease had been done \[[@B22]-[@B24]\], the host-specific infection and the relatively narrow lytic spectrum of phage is one of the obstacles to their further application. Individualized phage therapy may represent the future of phage therapy, where bacterial infections will be treated with phage combinations that have already been shown as effective for that particular bacterium. To overcome these limitations, strategies such as screening more lytic phages, combining phages with antibiotics, or administrating phages cocktails should be investigated \[[@B25],[@B26]\]. Therefore, it is very important to isolate novel and sensitive phages to enrich the phage arsenal \[[@B27]\].

All known *Acinetobacter baumannii* bacteriophages were summarized and compared in this research. There are nearly 20 *A. baumannii* phage strains reported in the literature mainly in 2012. Most of the phages genome length are about 40 kb. Just only thirteen complete *A. baumannii* phage genomes were sequenced and deposited in the GenBank database currently. Five of those genomes consist of an approximately 160 kb linear DNA molecule (*Acinetobacter* phage Ac42,Acj61,Acj9,133,and ZZ1), and are annotated as T4-like phage \[[@B5],[@B28]\]. The remaining eight phages contain a genome of 30--50 kb, and may be classified into two different groups according to sequence similarity. In one group, there are four phages with a linear genome, including phiAB1, which was already classified as a ϕKMV-like virus \[[@B29]\], phage YMC/09/02/B1251_ABA_BP \[[@B30]\], *Acinetobacter* phage AB3 and *Acinetobacter* phage Abp1. The other group includes four phages: AB1 (GenBank accession number: HM368260), AP22 (GenBank accession number: HE806280), phiAC-1 (GenBank accession number: JX560521), and our phage IME-AB2. We compared the growth characteristics and the genome of *A. baumannii* phage as shown in Table  [4](#T4){ref-type="table"}. The results indicated that the newly isolated phage IME-AB2 has a shorter latent and burst period than AB1 and AP22, which implied that the IME-AB2 was more lytic and the burst size produced by IME-AB2 was smaller than those phages \[[@B31]\]. All the listed *A. baumannii* bacteriophages or its lysin had been tested in treating bacterial infection such as inhibiting biofilm formation or effecting on host cell survival. Although the bacteriophage IME-AB2 could lyse the host bacteria and cleared the bacterial suspension in 4 hours, we observed that the resistant bacteria appeared and made the suspension turbid again in 24 hours. The easily emerging resistant bacteria after infection with phage might be an obstacle when fighting against bacterial infection with bacteriophage in the future.

###### 

**Comparative analysis of all known*Acinetobacter baumannii*bacteriophages**

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Name**                             **Morphology**                     **Genetic material**   **Genomic length**   **G C content (%)**   **Major protein sizes**     **Adsorption time (\>99%)**   **latent period**   **Burst size (PFU/cell)**   **Spectrum**   **Published time**   **Isolation**                            **Application**
  ------------------------------------ ---------------------------------- ---------------------- -------------------- --------------------- --------------------------- ----------------------------- ------------------- --------------------------- -------------- -------------------- ---------------------------------------- --------------------------------
  IME-AB2                              Myoviridae                         circular dsDNA         43665 bp             37.5                  38 kDa (35--130 kDa)        9 min                         20 min              62                          3 of 22                             hospital sewage, Beijing,China            

  AB1 \[[@B32]\]                       Caudovirales                       circular dsDNA         45159 bp             37.7                  33.1 kDa (14.4--97.4 kDa)                                 85 min              232                                        2012                 Wenzhou,China                             

  AP22 \[[@B33]\]                      Myoviridae                         circular dsDNA         46387 bp                                   32 kDa (18--87 kDa)         5 min                         40 min              240                         89 of 130      2012                 Clinical material, Russia                 

  phiAC-1 \[[@B34]\]                   Myoviridae                         circular dsDNA         43216 bp             38.5                                                                                                                                           2012                 First phage infect A. soli,South Korea    

  AB7-IBB2 \[[@B35]\]                  Podoviridae                        dsDNA                  170 kb                                                                 4 min                         25 min                                          19 of 39       2012                 India                                    Inhibit host biofilm formation

  AB7-IBB1 \[[@B36]\]                  Siphoviridae                       dsDNA                  75 kb                                      14.3-43 kDa                 5 min                         30 min              125                         23 of 39       2012                 India                                    Inhibit host biofilm formation

  ZZ1 \[[@B5]\]                        Myoviridae                         linear dsDNA           166682 bp            34.3                                                                            9 min               200                         3 of 23        2012                 fishpond water, Zhenzhou,\                
                                                                                                                                                                                                                                                                                          China                                    

  Abp1 \[[@B37]\]                      Podoviridae,phiKMV-like,T7 group   linear dsDNA           42185 bp             39.15                 29 kDa--116 kDa                                           10 min              350                         narrow         2012                 Chongqing, China                          

  AB3 \[[@B38]\]                       cubic phage                        linear dsDNA           31185 bp                                   35 kDa (35--264 kDa)                                      20 min              350                         wide           2012                 Chongqing, China                          

  YMC/09/ 02/B1251 ABA BP \[[@B30]\]   Podoviridae                        linear dsDNA           45364 bp             39.05                                                                                                                                          2012                 South Korea                               

  phikm18p \[[@B39]\]                  cubic phage                        dsDNA                  45 kb                                      39 kDa                                                                                                    wide           2012                 Taiwan                                   Cell survival test

  ABp53 \[[@B40]\]                     Myoviridae                         dsDNA                  95 kb                                      47-kDa protein                                            10 min              150                         27%            2011                 Sputum,Taiwan                             

  phiAB1 \[[@B29]\]                    Podoviridae, phiKMV-like phages    linear dsDNA           41526 bp                                                                                                                                                            2011                 Taiwan                                    

  Ac42,Acj61,Acj9,133 \[[@B28]\]       T4                                 linear dsDNA           160 kb                                                                                                                                                              2010                 USA                                       

  AB1 \[[@B41]\]                       Siphoviridae family                dsDNA                  45.2 kb to 46.9 kb                         14 to 80 kilo-dalton                                      18 min              409                         narrow         2010                 Marine sediment, Taiwan                   

  phi AB2 \[[@B42]\]                   Podoviridae, phiKMV-like phages    dsDNA                  40 kb                                                                  8 min                         10 min              200                         wide           2010                 Taiwan                                   Lyase AB2
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Conclusions
===========

A lytic *A. baumannii* bacteriophage IME-AB2 was isolated and characterized in this research. The complete genome of IME-AB2 was sequenced and compared to those of *A. baumannii* phage AB1, *A. baumannii* phage AP22, and A. *baumannii* phage phiAC-1 in detail. The genome of IME-AB2 was replete with novel genes without known relatives, which indicated that IME-AB2 was a novel and unique *A. baumannii* bacteriophage. Although the resistant *A. baumannii* appeared finally after infection with IME-AB2, the comprehensive understanding of the phage's characteristics is conducive to the treatment of multidrug-resistant *A. baumannii* in the future.

Methods
=======

Bacterial strains, Phage isolation, propagation, and titration
--------------------------------------------------------------

This study included 22 clinical strains of *A. baumannii* (MDR-AB1139, MDR-AB1, MDR-AB2, MDR-AB3, MDR-AB4, MDR-AB5, ... , MDR-AB19,MDR-AB20, MDR-AB21). All the clinical samples were taken as part of standard patient care at the PLA Hospital 307, Beijing, China. The patients were orally informed that the specimens would be used for screening bacteria and the tests were optional on laboratory sheet. Blood, sputum and skin swabs were collected from patients with consent under the Ethics Committee of the PLA Hospital 307. The protocol of screening bacteria was approved by the Ethics Committee of the PLA Hospital 307 and Beijing Institute of Microbiology and Epidemiology Ethics Committee.

Multidrug-resistant *A. baumannii* strain MDR-AB2 was used as an indicator for bacteriophage screening of raw sewage samples collected from PLA Hospital 307. Sewage samples were separated by centrifugation at 12,000 × *g* for 20 min. Following removal of the solid impurities by centrifugation, the supernatants were filtered through a 0.45 μm pore-size membrane filter to remove bacterial debris. Filtrate (4 ml) was added to 2 ml of 3× Luria-Bertani (LB) broth medium and mixed with 0.1 ml of *A. baumannii* overnight culture (OD~600~ = 0.6) to enrich the phage at 37°C overnight. Following enrichment, the culture was centrifuged at 12,000 × *g* for 10 min, and then the supernatant was filtered with a 0.45 μm pore-size membrane filter to remove the residual bacterial cells. The filtrate (0.1 ml) was mixed with 0.5 ml of *A. baumannii* in LB culture (OD~600~ = 0.6) and 5 ml of molten top soft nutrient agar (0.75% agar), which was then overlaid onto solidified base nutrient agar (1.5% agar) \[[@B43]\]. Following incubation for 6 h at 37°C, the clear phage plaques were picked from the plate. The phage titer was determined using the double-layered method previously described by Adams \[[@B44]\].

Phage concentration , purification and storage
----------------------------------------------

A single plaque was picked into 5 ml of LB medium containing MDR-AB2 (OD~600~ = 0.6) and cultured at 37°C for 6 h. A 5 ml aliquot of suspension was transferred into 500 ml of LB medium for culture at 37°C overnight. Chloroform was then added to the 500 ml of culture to a final concentration 0.1% before being mixed gently and allowed to stand at room temperature for about 30 min. Solid NaCl was added to the culture to a final concentration of 1 M, which was then incubated in an ice water bath for 1 h. The culture was centrifuged at 11,000 × *g* for 10 min to remove cell debris, and polyethylene glycol 6000 (PEG6000) was added to the supernatant to a final concentration of 10% (w/v) while slowly stirring with a magnetic stirrer at room temperature. This solution was transferred to a polypropylene centrifuge tube in an ice water bath and incubated at least 1 h to precipitate the phage particles. Following centrifugation (11,000 × *g* for 10 min at 4°C), the phage-containing precipitate was resuspended in 5 ml of SM buffer (50 mM Tris-Cl, 100 mM NaCl, 8 mM MgSO~4~, pH 7.5) \[[@B45]\]. An equal volume of chloroform was then added to separate the phage particles from PEG6000. Following centrifugation at 3,000 × *g* for 10 min, the aqueous phase was recovered and filtered through a 0.22 μm pore-size membrane filter to remove debris. The concentrated 1.0 ml of phage suspensions were layered on the top of a cesium chloride gradient solutions (density of 1.3 g/ml-0.45 g of cesium chloride in 1.0 ml of water; density of 1.5 g/ml-0.83 g of cesium chloride in 1.0 ml of water; density of 1.7 g/ml-1.28 g of cesium chloride in 1.0 ml of water) in 5.0 ml cellulose nitrate centrifuge tube \[[@B46]\]. After centrifugation in a Beckman Coulter Swinging Bucket Rotor (SW41, Ti) for 40 min at 100,000 × g, the concentrated phages at the visible band were collected by means of a capillary pipette. The purified phage was stored at 4°C.

Determination of lytic spectrum
-------------------------------

The host range was determined by spot test. Briefly, 0.5 ml of bacterial overnight culture was mixed with 5 ml of molten top soft nutrient agar (0.75% agar) and then overlaid on the surface of solidified base nutrient agar (1.5% agar). Once the top layer also solidified, 2 μl of the phage preparation(1 × 10^9^ pfu/ml) was spotted onto the plate, which was incubated for 6 h at 37°C.

Electron microscopy
-------------------

Phage stock solution was directly stained with phosphotungstic acid (PTA) for 2 min. After being dried at room temperature, the grid was examined using a Philips TECNAI-10 transmission electron microscope (TEM) to observe and record the morphology of the phage particles \[[@B41]\].

Extraction of phage genomic DNA
-------------------------------

Purified phage particles were treated with DNase I (1 μg/ml) (Takara) and RNase A (1 μg/ml) (Takara) for 30 min, and then the nucleases were inactivated at 80°C for 15 min. Ethylene diamine tetraacetic acid (EDTA) (20 mM), proteinase K (50 μg/ml) and sodium dodecyl sulfate (SDS) (0.5%) were then added and the mixture was incubated at 56°C for 1 h. Phage lysate was extracted with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1). Chloroform extraction was repeated until there was no phenol odor. An equal volume of isopropanol (AR grade) was added and the sample was incubated overnight at -20°C to precipitate the phage genomic DNA. The pellet was washed with 75% ethanol, and then deionized water was used to dissolve the precipitated genomic DNA.

Whole genome sequence and bioinformatics analysis
-------------------------------------------------

The genomic DNA of IME-AB2 was subjected to high-throughput sequencing using a Life Technologies Ion Personal Genome Machine Ion Torrent sequencer (San Francisco, CA) according to the manufacturer's instructions. The complete genome sequence of phage IME-AB2 was assembled using Velvet \[[@B47]\] and CLC Bio (Aarhus, Denmark), and annotated using RAST \[[@B48]\] and InterPro \[[@B49]\]. Sequence similarity analysis and comparison were performed using NCBI packages.
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